Filter

Disease Areas

Showing: 105 of 6 Product

Bylvay®

(odevixibat)

Bylvay® is a registered trademark of Albireo Pharma, Inc., an Ipsen company.

Full Prescribing Information

Patient Website

HCP Website

 

Dysport®

(abobotulinumtoxinA)

Dysport® is a registered trademark of Ipsen Biopharm Limited.

Full Prescribing Information including BOXED WARNING and Medication Guide

Patient Website

HCP Website

Iqirvo®

(elafibranor)

Iqirvo® is a registered trademark of Genfit S.A.

Full Prescribing Information

Patient Website

HCP Website

Onivyde®

(irinotecan liposome injection)

Onivyde® is a registered trademark of Ipsen Biopharm Limited.

Full Prescribing Information Including BOXED WARNING

Patient Website

HCP Website

Sohonos®

(palovarotene) capsules

Sohonos® is a registered trademark of Clementia Pharmaceuticals Inc.

Full Prescribing Information including BOXED WARNING and Medication Guide

Patient Website

HCP Website

Patient Safety is our Top Priority

We are committed to ensuring the continued safe and effective use of our medicines through the prompt detection, assessment, and communication of important safety information.

Alert

Report An Adverse Event (AE)

If you think you or someone you know has experienced an adverse event related to an Ipsen product or has a product complaint, please contact Ipsen Biopharmaceuticals, Inc., at +1 855 463 5127.

Adverse events may also be reported to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Alert

Request medical information

To request medical information on lpsen’s US products, please contact us at: 855-463-5127.

lf you are a Healthcare Professional who would like to request medical information on lpsen’s US products, you may also visit: www.ipsenmedicalinformation.com/US

©2026 Ipsen Biopharmaceuticals, Inc MPSC-US-000006

Related contact
Product & medical information
  • Add to contacts